Chiasma Stock Predictions

Healthcare > Biotechnology

Buy CHMA

*Your capital is at risk

$3.76

+0 (+0%)

At Close: May 27, 2022

Currently predicting for Tue, 16 Jun 2026

CHMA Live board

Community Bull/Bear

Target Next close

Join the CHMA prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

CHMA Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For CHMA

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

CHMA Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT CHIASMA

Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the bodys production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massa...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
EAT $140.46	13.43%	Jun 05
TPR $140.47	4.95%	Jun 04
LITE $905.00	1.83%	Jun 01
RUN $12.83	0.468%	May 06
GLBE $31.61	3.54%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by